United States Pharmaceuticals

VistaGen Therapeutics Inc (VTGN)

Track

Track

VistaGen Therapeutics Inc has recorded no insider trading activity within the past ninety days. The most recent transaction occurred on August 7, 2023, involving a significant purchase by Commodore Capital LP. Historical data indicates various buying patterns by executives and entities, though these events occurred well over three months ago.
Ticker: VTGN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for VistaGen Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.9
COMMODORE CAPITAL LP Large shareholder
Transaction date
Purchase
Price
323.13
Quantity 51,236 -16.8%
Value US$2,628,735
1.3
GIN JERRY B Non-Executive Director
Transaction date
Purchase
Price
463.95
Quantity 33,474 +43.2%
Value US$3,176,657
1.3
GIN JERRY B Non-Executive Director
Transaction date
Purchase
Price
148.97
Quantity 16,941 -37.0%
Value US$2,016,797
1.6
Adler Reid G. CHIEF LEGAL OFFICER Officer
Transaction date
Purchase
Price
0.17
Quantity 300,000 +866.3%
Value US$50,910
1.5
Singh Shawn CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
0.17
Quantity 600,000 +2287.1%
Value US$103,200
3.1
SAXE JON S Non-Executive Director
Transaction date
Purchase
Price
0.69
Quantity 30,000 +150.0%
Value US$20,700
SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER
Transaction date
Purchase
Price
0.34
Quantity 15,000 +inf%
Value US$5,100
3.1
SAXE JON S
Transaction date
Purchase
Price
1.27
Quantity 7,920 +65.6%
Value US$10,086
3.1
SAXE JON S
Transaction date
Purchase
Price
1.26
Quantity 12,080 +inf%
Value US$15,201
GIN JERRY B
Transaction date
Purchase
Price
0.00
Quantity 50,000
Value US$0
GIN JERRY B
Transaction date
Purchase
Price
0.00
Quantity 50,000
Value US$0
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-09 2023-08-07 B Purchase
1.9
COMMODORE CAPITAL LP
Large shareholder
51,236 -16.8%
323.13
US$2,628,735 		51,236 -16.8% 323.13 US$2,628,735
2022-08-22 2022-08-18 B Purchase
1.3
GIN JERRY B
Non-Executive Director
33,474 +43.2%
463.95
US$3,176,657 		33,474 +43.2% 463.95 US$3,176,657
2022-08-22 2022-08-18 B Purchase
1.3
GIN JERRY B
Non-Executive Director
16,941 -37.0%
148.97
US$2,016,797 		16,941 -37.0% 148.97 US$2,016,797
2022-08-19 2022-08-17 B Purchase
1.6
Adler Reid G.

CHIEF LEGAL OFFICER

Officer
300,000 +866.3%
0.17
US$50,910 		300,000 +866.3% 0.17 US$50,910
2022-08-18 2022-08-17 B Purchase
1.5
Singh Shawn

CHIEF EXECUTIVE OFFICER

Executive Director
600,000 +2287.1%
0.17
US$103,200 		600,000 +2287.1% 0.17 US$103,200
2022-07-14 2022-07-12 S Sale
3.0
Venrock Healthcare Capital Partners II, L.P.
Large shareholder
60,000 -0.3%
0.89
US$53,400 		60,000 -0.3% 0.89 US$53,400
2020-08-24 2020-08-21 B Purchase
3.1
SAXE JON S
Non-Executive Director
30,000 +150.0%
0.69
US$20,700 		30,000 +150.0% 0.69 US$20,700
2019-11-21 2019-11-20 B Purchase SNODGRASS H. RALPH

PRES./CHIEF SCIENTIFIC OFFICER
15,000 +inf%
0.34
US$5,100 		15,000 +inf% 0.34 US$5,100
2019-03-14 2019-03-14 B Purchase
3.1
SAXE JON S
7,920 +65.6%
1.27
US$10,086 		7,920 +65.6% 1.27 US$10,086
2019-03-14 2019-03-13 B Purchase
3.1
SAXE JON S
12,080 +inf%
1.26
US$15,201 		12,080 +inf% 1.26 US$15,201
2017-06-01 2017-05-31 B Purchase GIN JERRY B
50,000
0.00
US$0 		50,000 0.00 US$0
2017-06-01 2017-05-31 B Purchase GIN JERRY B
50,000
0.00
US$0 		50,000 0.00 US$0
Explore more

More insider trading research around VistaGen Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America